tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

CARM Stock Latest News

Carisma Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
The FlyCarisma Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
6d ago
CARM
Carisma investors should ‘stay the course,’ says D. Boral Capital
PremiumThe Fly
Carisma investors should ‘stay the course,’ says D. Boral Capital
10d ago
CARM
Carisma Therapeutics downgraded to Neutral from Outperform at Baird
PremiumThe Fly
Carisma Therapeutics downgraded to Neutral from Outperform at Baird
10d ago
CARM
Carisma Therapeutics downgraded to In Line from Outperform at Evercore ISI
PremiumThe Fly
Carisma Therapeutics downgraded to In Line from Outperform at Evercore ISI
11d ago
CARM
MRNA
Carisma Therapeutics downgraded to Neutral from Buy at BTIG
PremiumThe Fly
Carisma Therapeutics downgraded to Neutral from Buy at BTIG
13d ago
CARM
Carisma Therapeutics price target lowered to $12 from $24 at D. Boral Capital
PremiumThe FlyCarisma Therapeutics price target lowered to $12 from $24 at D. Boral Capital
13d ago
CARM
Carisma Therapeutics announces restructuring, 34% workforce reduction
Premium
The Fly
Carisma Therapeutics announces restructuring, 34% workforce reduction
13d ago
CARM
Carisma Therapeutics Restructures Amid Strategic Refocus
Premium
Company Announcements
Carisma Therapeutics Restructures Amid Strategic Refocus
13d ago
8K
CARM
Carisma Therapeutics price target lowered to $5 from $8 at H.C. Wainwright
PremiumThe Fly
Carisma Therapeutics price target lowered to $5 from $8 at H.C. Wainwright
27d ago
CARM
Carisma Therapeutics reports data from its CAR-M therapy
PremiumThe Fly
Carisma Therapeutics reports data from its CAR-M therapy
1M ago
CARM
MRNA
Carisma Therapeutics reports Q3 EPS (31c), consensus (26c)
PremiumThe Fly
Carisma Therapeutics reports Q3 EPS (31c), consensus (26c)
2M ago
CARM
Carisma to present new data on CAR-M therapy for hepatocellular carcinoma
PremiumThe Fly
Carisma to present new data on CAR-M therapy for hepatocellular carcinoma
2M ago
CARM
MRNA
Carisma Therapeutics, Inc. (CARM) Q3 Earnings Cheat Sheet
PremiumPre-EarningsCarisma Therapeutics, Inc. (CARM) Q3 Earnings Cheat Sheet
2M ago
CARM
Leadership Transition at Carisma Therapeutics’ Board of Directors
Premium
Company Announcements
Leadership Transition at Carisma Therapeutics’ Board of Directors
2M ago
8K
CARM
Alphabet upgraded, Boeing downgraded: Wall Street’s top analyst calls
Premium
The Fly
Alphabet upgraded, Boeing downgraded: Wall Street’s top analyst calls
2M ago
BA
CWH
Carisma Therapeutics initiated with a Buy at EF Hutton
PremiumThe Fly
Carisma Therapeutics initiated with a Buy at EF Hutton
2M ago
CARM
Carisma Therapeutics and Moderna expand collaboration to develop CAR-M therapies
PremiumThe Fly
Carisma Therapeutics and Moderna expand collaboration to develop CAR-M therapies
3M ago
CARM
MRNA
Carisma Therapeutics reports Q2 EPS (27c), consensus (30c)
PremiumThe Fly
Carisma Therapeutics reports Q2 EPS (27c), consensus (30c)
5M ago
CARM
Carisma Therapeutics Board Changes and New Compensation Plans
PremiumCompany Announcements
Carisma Therapeutics Board Changes and New Compensation Plans
6M ago
8K
CARM
Carisma Therapeutics announces changes to its board of directors
PremiumThe FlyCarisma Therapeutics announces changes to its board of directors
6M ago
CARM
Carisma Therapeutics nominates first candidate under collaboration with Moderna
Premium
The Fly
Carisma Therapeutics nominates first candidate under collaboration with Moderna
6M ago
CARM
MRNA
Carisma Therapeutics granted FDA Fast Track designation for CT-0525
Premium
The Fly
Carisma Therapeutics granted FDA Fast Track designation for CT-0525
6M ago
CARM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >